Cell cycle regulation by glucosamine in human pulmonary epithelial cells

Pulmonary Pharmacology and Therapeutics

Volumn 26, Issue 2, 2013, Pages 195-204

  Chuang, Kun Han ^a   Lu, Chih Shen ^b   Kou, Yu Ru ^a   Wu, Yuh Lin ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b CHENG HSIN GENERAL HOSPITAL   (Taiwan)

Author keywords

Apoptosis; Cell cycle; Cell proliferation; Epithelial cells; Glucosamine

Indexed keywords

GLUCOSAMINE; HEME OXYGENASE 1; MESSENGER RNA; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN;

APOPTOSIS; ARTICLE; CELL COUNT; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; PROTEIN TRANSPORT;

APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL LINE; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; EPITHELIAL CELLS; GLUCOSAMINE; HUMANS; LUNG; PHOSPHORYLATION; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84874564121     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2012.10.007     Document Type: Article

References (42)

1. Janssen-Heininger Y.M., Poynter M.E., Aesif S.W., Pantano C., Ather J.L., Reynaert N.L., et al. Nuclear factor kappaB, airway epithelium, and asthma: avenues for redox control. Proc Am Thorac 2009, 6:249-255.
2. Gaur U., Aggarwal B.B. Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem Pharmacol 2003, 66:1403-1408.
3. Liao W., Goh F.Y., Betts R.J., Kemeny D.M., Tam J., Bay B.H., et al. A novel anti-apoptotic role for apolipoprotein L2 in IFN-gamma-induced cytotoxicity in human bronchial epithelial cells. J Cell Physiol 2011, 226:397-406.
4. Wang S.X., Laverty S., Dumitriu M., Plaas A., Grynpas M.D. The effects of glucosamine hydrochloride on subchondral bone changes in an animal model of osteoarthritis. Arthritis Rheum 2007, 56:1537-1548.
5. Largo R., Martinez-Calatrava M.J., Sanchez-Pernaute O., Marcos M.E., Moreno-Rubio J., Aparicio C., et al. Effect of a high dose of glucosamine on systemic and tissue inflammation in an experimental model of atherosclerosis aggravated by chronic arthritis. Am J Physiol Heart Circ Physiol 2009, 297:H268-H276.
6. Kim Y.K., Park J.H., Park S.H., Lim B., Baek W.K., Suh S.I. Protective role of glucagon-like peptide-1 against glucosamine-induced cytotoxicity in pancreatic beta cells. Cell Physiol Biochem 2010, 25:211-220.
7. Zhang L., Liu W.S., Han B.Q., Peng Y.F., Wang D.F. Antitumor activities of D-glucosamine and its derivatives. J Zhejiang Univ Sci B 2006, 7:608-614.
8. Wang Z., Liang R., Huang G.S., Piao Y., Zhang Y.Q., Wang A.Q., et al. Glucosamine sulfate-induced apoptosis in chronic myelogenous leukemia K562 cells is associated with translocation of cathepsin D and downregulation of Bcl-xL. Apoptosis 2006, 11:1851-1860.
9. Sherr C.J., Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999, 13:1501-1512.
10. Zarkowska T., Mittnacht S. Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases. J Biol Chem 1997, 272:12738-12746.
11. Choi H.C., Lee K.Y., Lee D.H., Kang Y.J. Heme oxygenase-1 induced by aprotinin inhibits vascular smooth muscle cell proliferation through cell cycle arrest in hypertensive rats. Korean J Physiol Pharmacol 2009, 13:309-313.
12. Lee P.J., Alam J., Wiegand G.W., Choi A.M. Overexpression of heme oxygenase-1 in human pulmonary epithelial cells results in cell growth arrest and increased resistance to hyperoxia. Proc Natl Acad Sci U S A 1996, 93:10393-10398.
13. Gonzalez-Michaca L., Farrugia G., Croatt A.J., Alam J., Nath K.A. Heme: a determinant of life and death in renal tubular epithelial cells. Am J Physiol Renal Physiol 2004, 286:F370-F377.
14. Wu Y.L., Kou Y.R., Ou H.L., Chien H.Y., Chuang K.H., Liu H.H., et al. Glucosamine regulation of LPS-mediated inflammation in human bronchial epithelial cells. Eur J Pharmacol 2010, 635:219-226.
15. Nevins J.R. The Rb/E2F pathway and cancer. Hum Mol Genet 2001, 10:699-703.
16. Liu P.Y., Chan J.Y., Lin H.C., Wang S.L., Liu S.T., Ho C.L., et al. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells. Mol Cancer Res 2008, 6:1204-1214.
17. Du Bois R.M. Strategies for treating idiopathic pulmonary fibrosis. Nat Rev Drug Discov 2010, 9:129-140.
18. Chen H., Cowan M.J., Hasday J.D., Vogel S.N., Medvedev A.E. Tobacco smoking inhibits expression of proinflammatory cytokines and activation of IL-1R-associated kinase, p38, and NF-kappaB in alveolar macrophages stimulated with TLR2 and TLR4 agonists. J Immunol 2007, 179:6097-6106.
19. Runkel D.R., Cupp M.J. Glucosamine sulfate use in osteoarthritis. Am J Health Syst Pharm 1999, 56:267-269.
20. Nakamura H., Shibakawa A., Tanaka M., Kato T., Nishioka K. Effects of glucosamine hydrochloride on the production of prostaglandin E2, nitric oxide and metalloproteases by chondrocytes and synoviocytes in osteoarthritis. Clin Exp Rheumatol 2004, 22:293-299.
21. Valvason C., Musacchio E., Pozzuoli A., Ramonda R., Aldegheri R., Punzi L. Influence of glucosamine sulphate on oxidative stress in human osteoarthritic chondrocytes: effects on HO-1, p22Phox and iNOS expression. Rheumatology 2008, 47:31-35.
22. Lin Y.C., Liang Y.C., Sheu M.T., Lin Y.C., Hsieh M.S., Chen T.F., et al. Chondroprotective effects of glucosamine involving the p38 MAPK and Akt signaling pathways. Rheumatol Int 2008, 28:1009-1016.
23. Gouze J.N., Gouze E., Popp M.P., Bush M.L., Dacanay E.A., Kay J.D., et al. Exogenous glucosamine globally protects chondrocytes from the arthritogenic effects of IL-1β. Arthritis Res Ther 2006, 8:R173.
24. Byron C.R., Orth M.W., Venta P.J., Lloyd J.W., Caron J.P. Influence of glucosamine on matrix metalloproteinase expression and activity in lipopolysaccharide-stimulated equine chondrocytes. Am J Vet Res 2003, 64:666-671.
25. Chen J.T., Chen P.L., Chang Y.H., Chien M.W., Chen Y.H., Lu D.W., et al. Glucosamine sulfate inhibits leukocyte adhesion in response to cytokine stimulation of retinal pigment epithelial cells in vitro. Exp Eye Res 2006, 83:1052-1062.
26. Liang C.M., Tai M.C., Chang Y.H., Chen Y.H., Chen C.L., Chien M.W., et al. Glucosamine inhibits epidermal growth factor-induced proliferation and cell-cycle progression in retinal pigment epithelial cells. Mol Vis 2010, 16:2559-2571.
27. Driscoll B., Wu L., Buckley S., Hall F.L., Anderson K.D., Warburton D. Cyclin D1 antisense RNA destabilizes pRb and retards lung cancer cell growth. Am J Physiol 1997, 273:L941-L949.
28. Kato J., Matsushime H., Hiebert S.W., Ewen M.E., Sherr C.J. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev 1993, 7:331-342.
29. Ferguson K.L., Slack R.S. The Rb pathway in neurogenesis. Neuroreport 2001, 12:A55-A62.
30. Tomida A., Suzuki H., Kim H.D., Tsuruo T. Glucose-regulated stresses cause decreased expression of cyclin D1 and hypophosphorylation of retinoblastoma protein in human cancer cells. Oncogene 1996, 13:2699-2705.
31. Hunter T., Pines J. Cyclins and cancer. II: cyclin D and CDK inhibitors come of age. Cell 1994, 79:573-582.
32. Masson E., Wiernsperger N., Lagarde M., El B.S. Glucosamine induces cell-cycle arrest and hypertrophy of mesangial cells: implication of gangliosides. Biochem J 2005, 388:537-544.
33. Bendjennat M., Boulaire J., Jascur T., Brickner H., Barbier V., Sarasin A., et al. UV irradiation triggers ubiquitin-dependent degradation of p21(WAF1) to promote DNA repair. Cell 2003, 114:599-610.
34. Sheaff R.J., Singer J.D., Swanger J., Smitherman M., Roberts J.M., Clurman B.E. Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination. Mol Cell 2000, 5:403-410.
35. Lee J.Y., Kim H.S., Kim J.Y., Sohn J. Nuclear translocation of p21(WAF1/CIP1) protein prior to its cytosolic degradation by UV enhances DNA repair and survival. Biochem Biophys Res Commun 2009, 390:1361-1366.
36. Rodríguez-Vilarrupla A., Díaz C., Canela N., Rahn H.P., Bachs O., Agell N. Identification of the nuclear localization signal of p21(cip1) and consequences of its mutation on cell proliferation. FEBS Lett 2002, 531:319-323.
37. Coqueret O. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment?. Trends Cell Biol 2003, 13:65-70.
38. el-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993, 75:817-825.
39. Shibata M.A., Yoshidome K., Shibata E., Jorcyk C.L., Green J.E. Suppression of mammary carcinoma growth in vitro and in vivo by inducible expression of the Cdk inhibitor p21. Cancer Gene Ther 2001, 8:23-35.
40. Lincet H., Poulain L., Remy J.S., Deslandes E., Duigou F., Gauduchon P., et al. The p21(cip1/waf1) cyclin-dependent kinase inhibitor enhances the cytotoxic effect of cisplatin in human ovarian carcinoma cells. Cancer Lett 2000, 161:17-26.
41. Xu S.Q., El-Deiry W.S. p21(WAF1/CIP1) inhibits initiator caspase cleavage by TRAIL death receptor DR4. Biochem Biophys Res Commun 2000, 269:179-190.
42. Suzuki A., Tsutomi Y., Akahane K., Araki T., Miura M. Resistance to Fas-mediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP. Oncogene 1998, 17:931-939.